Literature DB >> 22985881

Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Susan E Puckett1, Kaleb A Reese, Georgi M Mitev, Valerie Mullen, Rudd C Johnson, Kyle R Pomraning, Brett L Mellbye, Lucas D Tilley, Patrick L Iversen, Michael Freitag, Bruce L Geller.   

Abstract

Peptide phosphorodiamidate morpholino oligomers (PPMOs) are synthetic DNA mimics that bind cRNA and inhibit bacterial gene expression. The PPMO (RFF)(3)RXB-AcpP (where R is arginine, F, phenylalanine, X is 6-aminohexanoic acid, B is β-alanine, and AcpP is acyl carrier protein) is complementary to 11 bases of the essential gene acpP (which encodes acyl carrier protein). The MIC of (RFF)(3)RXB-AcpP was 2.5 μM (14 μg/ml) in Escherichia coli W3110. The rate of spontaneous resistance of E. coli to (RFF)(3)RXB-AcpP was 4 × 10(-7) mutations/cell division. A spontaneous (RFF)(3)RXB-AcpP-resistant mutant (PR200.1) was isolated. The MIC of (RFF)(3)RXB-AcpP was 40 μM (224 μg/ml) for PR200.1. The MICs of standard antibiotics for PR200.1 and W3110 were identical. The sequence of acpP was identical in PR200.1 and W3110. PR200.1 was also resistant to other PPMOs conjugated to (RFF)(3)RXB or peptides with a similar composition or pattern of cationic and nonpolar residues. Genomic sequencing of PR200.1 identified a mutation in sbmA, which encodes an active transport protein. In separate experiments, a (RFF)(3)RXB-AcpP-resistant isolate (RR3) was selected from a transposome library, and the insertion was mapped to sbmA. Genetic complementation of PR200.1 or RR3 with sbmA restored susceptibility to (RFF)(3)RXB-AcpP. Deletion of sbmA caused resistance to (RFF)(3)RXB-AcpP. We conclude that resistance to (RFF)(3)RXB-AcpP was linked to the peptide and not the phosphorodiamidate morpholino oligomer, dependent on the composition or repeating pattern of amino acids, and caused by mutations in sbmA. The data further suggest that (RFF)(3)R-XB PPMOs may be transported across the plasma membrane by SbmA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985881      PMCID: PMC3497173          DOI: 10.1128/AAC.00850-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Mutation frequencies and antibiotic resistance.

Authors:  J L Martinez; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

Review 2.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Authors:  Lucas D Tilley; Orion S Hine; Jill A Kellogg; Jed N Hassinger; Dwight D Weller; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 4.  Antimicrobial peptides with cell-penetrating peptide properties and vice versa.

Authors:  Katrin Splith; Ines Neundorf
Journal:  Eur Biophys J       Date:  2011-02-19       Impact factor: 1.733

5.  Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival.

Authors:  K LeVier; R W Phillips; V K Grippe; R M Roop; G C Walker
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

6.  Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.

Authors:  Günter Harth; Paul C Zamecnik; David Tabatadze; Katherine Pierson; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

7.  Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

Authors:  Bruce L Geller; Jesse Deere; Lucas Tilley; Patrick L Iversen
Journal:  J Antimicrob Chemother       Date:  2005-05-04       Impact factor: 5.790

8.  Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli.

Authors:  Lucas D Tilley; Brett L Mellbye; Susan E Puckett; Patrick L Iversen; Bruce L Geller
Journal:  J Antimicrob Chemother       Date:  2006-10-31       Impact factor: 5.790

9.  Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.

Authors:  P Yorgey; J Lee; J Kördel; E Vivas; P Warner; D Jebaratnam; R Kolter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

Authors:  Brett L Mellbye; Susan E Puckett; Luke D Tilley; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

View more
  18 in total

1.  Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35).

Authors:  Giulia Runti; Maria del Carmen Lopez Ruiz; Tatiana Stoilova; Rohanah Hussain; Matthew Jennions; Hassanul G Choudhury; Monica Benincasa; Renato Gennaro; Konstantinos Beis; Marco Scocchi
Journal:  J Bacteriol       Date:  2013-09-27       Impact factor: 3.490

2.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

3.  Mechanism of Escherichia coli resistance to Pyrrhocoricin.

Authors:  Shalini Narayanan; Joyanta K Modak; Catherine S Ryan; Jose Garcia-Bustos; John K Davies; Anna Roujeinikova
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

4.  Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Authors:  James J Howard; Carolyn R Sturge; Dina A Moustafa; Seth M Daly; Kimberly R Marshall-Batty; Christina F Felder; Danniel Zamora; Marium Yabe-Gill; Maria Labandeira-Rey; Stacey M Bailey; Michael Wong; Joanna B Goldberg; Bruce L Geller; David E Greenberg
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  Functional and structural study of the dimeric inner membrane protein SbmA.

Authors:  Natalia Corbalan; Giulia Runti; Conrado Adler; Sonia Covaceuszach; Robert C Ford; Doriano Lamba; Konstantinos Beis; Marco Scocchi; Paula A Vincent
Journal:  J Bacteriol       Date:  2013-09-27       Impact factor: 3.490

6.  Vitamin B12 as a carrier of peptide nucleic acid (PNA) into bacterial cells.

Authors:  Marcin Równicki; Monika Wojciechowska; Aleksandra J Wierzba; Jakub Czarnecki; Dariusz Bartosik; Dorota Gryko; Joanna Trylska
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

7.  Integrated roles of BclA and DD-carboxypeptidase 1 in Bradyrhizobium differentiation within NCR-producing and NCR-lacking root nodules.

Authors:  Quentin Barrière; Ibtissem Guefrachi; Djamel Gully; Florian Lamouche; Olivier Pierre; Joël Fardoux; Clémence Chaintreuil; Benoît Alunni; Tatiana Timchenko; Eric Giraud; Peter Mergaert
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

8.  Time-Resolved Tracking of Mutations Reveals Diverse Allele Dynamics during Escherichia coli Antimicrobial Adaptive Evolution to Single Drugs and Drug Pairs.

Authors:  Rachel A Hickman; Christian Munck; Morten O A Sommer
Journal:  Front Microbiol       Date:  2017-05-24       Impact factor: 5.640

9.  Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.

Authors:  Dilay Hazal Ayhan; Yusuf Talha Tamer; Mohammed Akbar; Stacey M Bailey; Michael Wong; Seth M Daly; David E Greenberg; Erdal Toprak
Journal:  PLoS Biol       Date:  2016-09-15       Impact factor: 8.029

10.  (Non-)translational medicine: targeting bacterial RNA.

Authors:  Adam M Dinan; Brendan J Loftus
Journal:  Front Genet       Date:  2013-11-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.